Movement Alert｜Sinopharm Group Rises 3.04% in Regular Trading, Technical Recovery Post Ex-Dividend Coupled with Strategic Cooperation Catalyst

Market Focus06-29

On June 29, Sinopharm Group rose 3.04% in regular trading, trading at HK$16.26/share, with turnover of HK$38.70 million.

On the news front, the stock is experiencing a technical recovery following its ex-dividend date on June 23. The company recently signed a strategic cooperation agreement with Sunshine Lake Pharma, under which both parties will deeply integrate distribution resources and innovative product portfolios to accelerate market coverage of innovative drugs. Additionally, the company's annual general meeting previously approved a buyback authorization of up to 10% of issued H shares, providing price support. The final dividend of RMB 0.69 per share will be paid on August 18, with the record date set for June 30.

Within the Health Care Distributors sector, individual stocks showed mixed performance: 160 Health up 6.65%, SH Pharma up 2.92%, Baiyunshan PH up 2.89%, YSB up 11.3%, Guanze Medical down 3.51%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1116612269?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-29 11:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1116612269","market":"us","top_or_hot":-1,"title":"Movement Alert｜Sinopharm Group Rises 3.04% in Regular Trading, Technical Recovery Post Ex-Dividend Coupled with Strategic Cooperation Catalyst","media":"Market Focus","content":"<p><p>On June 29, Sinopharm Group rose 3.04% in regular trading, trading at HK$16.26/share, with turnover of HK$38.70 million.</p><p>On the news front, the stock is experiencing a technical recovery following its ex-dividend date on June 23. The company recently signed a strategic cooperation agreement with Sunshine Lake Pharma, under which both parties will deeply integrate distribution resources and innovative product portfolios to accelerate market coverage of innovative drugs. Additionally, the company's annual general meeting previously approved a buyback authorization of up to 10% of issued H shares, providing price support. The final dividend of RMB 0.69 per share will be paid on August 18, with the record date set for June 30.</p><p>Within the Health Care Distributors sector, individual stocks showed mixed performance: 160 Health up 6.65%, SH Pharma up 2.92%, Baiyunshan PH up 2.89%, YSB up 11.3%, Guanze Medical down 3.51%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Sinopharm Group Rises 3.04% in Regular Trading, Technical Recovery Post Ex-Dividend Coupled with Strategic Cooperation Catalyst</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Sinopharm Group Rises 3.04% in Regular Trading, Technical Recovery Post Ex-Dividend Coupled with Strategic Cooperation Catalyst\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-29 11:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 29, Sinopharm Group rose 3.04% in regular trading, trading at HK$16.26/share, with turnover of HK$38.70 million.</p><p>On the news front, the stock is experiencing a technical recovery following its ex-dividend date on June 23. The company recently signed a strategic cooperation agreement with Sunshine Lake Pharma, under which both parties will deeply integrate distribution resources and innovative product portfolios to accelerate market coverage of innovative drugs. Additionally, the company's annual general meeting previously approved a buyback authorization of up to 10% of issued H shares, providing price support. The final dividend of RMB 0.69 per share will be paid on August 18, with the record date set for June 30.</p><p>Within the Health Care Distributors sector, individual stocks showed mixed performance: 160 Health up 6.65%, SH Pharma up 2.92%, Baiyunshan PH up 2.89%, YSB up 11.3%, Guanze Medical down 3.51%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01099","symbol_name":"国药控股","start_time":0,"source_url":"","article_id":"1116612269","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1116612269","pubTimestamp":1782703853,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 29, Sinopharm Group rose 3.04% in regular trading, trading at HK$16.26/share, with turnover of HK$38.70 million.On the news front, the stock is experiencing a technical recovery following its...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01099":"国药控股"},"translate_title":"异动快讯|国药集团常规交易涨3.04%除息后技术修复叠加战略合作催化剂","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01099":1},"content_text":"On June 29, Sinopharm Group rose 3.04% in regular trading, trading at HK$16.26/share, with turnover of HK$38.70 million.On the news front, the stock is experiencing a technical recovery following its ex-dividend date on June 23. The company recently signed a strategic cooperation agreement with Sunshine Lake Pharma, under which both parties will deeply integrate distribution resources and innovative product portfolios to accelerate market coverage of innovative drugs. Additionally, the company's annual general meeting previously approved a buyback authorization of up to 10% of issued H shares, providing price support. The final dividend of RMB 0.69 per share will be paid on August 18, with the record date set for June 30.Within the Health Care Distributors sector, individual stocks showed mixed performance: 160 Health up 6.65%, SH Pharma up 2.92%, Baiyunshan PH up 2.89%, YSB up 11.3%, Guanze Medical down 3.51%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1116612269","isCrawlerRequest":true}